Nirmala Bhoo-Pathy, Cuno S P M Uiterwaal, Vincent K Dik, Suzanne M Jeurnink, Bodil H Bech, Kim Overvad, Jytte Halkjær, Anne Tjønneland, Marie-Christine Boutron-Ruault, Guy Fagherazzi, Antoine Racine, Verena A Katzke, Kuanrong Li, Heiner Boeing, Anna Floegel, Anna Androulidaki, Christina Bamia, Antonia Trichopoulou, Giovanna Masala, Salvatore Panico, Paolo Crosignani, Rosario Tumino, Paolo Vineis, Petra H M Peeters, Oxana Gavrilyuk, Guri Skeie, Elisabete Weiderpass, Eric J Duell, Marcial Arguelles, Esther Molina-Montes, Carmen Navarro, Eva Ardanaz, Miren Dorronsoro, Björn Lindkvist, Peter Wallström, Malin Sund, Weimin Ye, Kay-Tee Khaw, Nick Wareham, Timothy J Key, Ruth C Travis, Talita Duarte-Salles, Heinz Freisling, Idlir Licaj, Valentina Gallo, Dominique S Michaud, Elio Riboli, H Bas Bueno-De-Mesquita
BACKGROUND & AIMS: Few modifiable risk factors have been implicated in the etiology of pancreatic cancer. There is little evidence for the effects of caffeinated coffee, decaffeinated coffee, or tea intake on risk of pancreatic cancer. We investigated the association of total coffee, caffeinated coffee, decaffeinated coffee, and tea consumption with risk of pancreatic cancer. METHODS: This study was conducted within the European Prospective Investigation into Nutrition and Cancer cohort, comprising male and female participants from 10 European countries...
November 2013: Clinical Gastroenterology and Hepatology